Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Condition aggravated, Injection site erythema, Injection site pain, Injection site swelling, Neuralgia
Clinical narrative: Injetion site was painful; Injection site red; Injection site swollen; from the injection site down to the elbow area-AE: pain; from the injection site down to the elbow area-AE: pain; from the injection site down to the elbow area-AE: swelling; from the injection site down to the elbow area-AE: swelling; from the injection site down to the elbow area-AE: redness; worsening nerve pain/ neuropathy pain has become worse; worsening nerve pain/ neuropathy pain has become worse; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Gabapentin (was prescribed with Gabapentin three times a day). Concurrent medical conditions included shingles (had an episode in May 2023) and neuropathic pain (has been having neuropathy pain since shingles in May 2023).   On 29-JAN-2024, the patient received the 1st dose of Shingrix (intramuscular, left arm). On an unknown date, an unknown time after receiving Shingrix, the patient experienced injection site pain (Verbatim: Injetion site was painful), injection site erythema (Verbatim: Injection site red), injection site swelling (Verbatim: Injection site swollen), pain in arm (Verbatim: from the injection site down to the elbow area-AE: pain), pain in elbow (Verbatim: from the injection site down to the elbow area-AE: pain), swelling arm (Verbatim: from the injection site down to the elbow area-AE: swelling), swelling of elbows (Verbatim: from the injection site down to the elbow area-AE: swelling), erythema of extremities (Verbatim: from the injection site down to the elbow area-AE: redness), neuralgia (Verbatim: worsening nerve pain/ neuropathy pain has become worse) and condition aggravated (Verbatim: worsening nerve pain/ neuropathy pain has become worse). The outcome of the injection site pain, injection site erythema, pain in arm, pain in elbow, erythema of extremities, neuralgia and condition aggravated were not resolved and the outcome of the injection site swelling, swelling arm and swelling of elbows were unknown.   It was unknown if the reporter considered the injection site pain, injection site erythema, injection site swelling, pain in arm, pain in elbow, swelling arm, swelling of elbows, erythema of extremities, neuralgia and condition aggravated to be related to Shingrix.     It was unknown if the company considered the injection site pain, injection site erythema, injection site swelling, pain in arm, pain in elbow, swelling arm, swelling of elbows, erythema of extremities, neuralgia and condition aggravated to be related to Shingrix.   Additional Information: GSK Receipt Date: 04-MAR-2024 The patient self-reported this case. The patient got her 1st dose of Shingrix vaccine at a local pharmacy.  The patient reported that her injection site was painful, was red and swollen from the injection site down to the elbow area, (adverse event: pain), (adverse event: swelling), (adverse event: redness). Patient reported that after getting the Shingrix vaccine, the shingles neuropathy pain had become worse.  Patient reported it has not subsided (adverse event: worsening nerve pain).  Not all information was provided.  The reporter consented to follow up.